The reproducibility of reporting squamous lesions by the Bethesda System (TBS) was
evaluated by distributing 20 slides to be classified among 5 panelists considered experts in …

Federal regulations require laboratories to re‐examine negative cervical smears from the 5
yr preceding a diagnosis of high‐grade squamous intraepithelial lesion (HSIL) or carcinoma …

OBJECTIVE: To determine the correlation between cervical smear quality and the rate of
detecting significant epithelial abnormalities. STUDY DESIGN: Smear quality was assessed …

In a study of variability in the diagnosis of epithelial abnormalities, cervical smears with
abnormalities of different severity were rescreened twice by 19 observers with an interval of …

A retrospective 7‐mo study (June 1, 1993‐December 31, 1993) was performed to evaluate
the significance of reporting atypical squamous cells of undetermined significance (ASCUS) …

Intraobserver and interobserver variability in assessing the quality of cervical smears, as
measured by the presence or absence of endocervical columnar cells and squamous …

To investigate the accuracy rates of cytology in abnormal cervical smears and the factors
contributing to a discrepant diagnosis between cytology and histology repots of cervical …

Abstract Although The Bethesda System 2001 attempted to standardize the criteria for
specimen adequacy, much confusion still exists, which includes the significance of …

One hundred and ten cervical smears were circulated to five specialist consultant
cytopathologists and five consultant histopathologists. Of these smears, 100 were …

The cytologic histories of 376 women presenting with invasive carcinoma of the cervix were
analyzed. In total, 202 (53.7%) of these women had had 355 smears taken during the three …